The global CBD consumer health market size is anticipated to reach USD 61.17 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 16.2% from 2024 to 2030. The growing adoption of cannabidiol (CBD) as a consumer health product due to increasing awareness about the health benefits of CBD and rise in the number of countries legalizing these products are the key factors driving the growth. Furthermore, the changing buyer perception and attitude toward cannabidiol products is an important factor bolstering the revenue growth.
Based on product type, nutraceuticals dominated the market with a revenue share of 63.9% in 2023. Rising awareness regarding cannabidiol, changing user preferences from chemical-based ingredients to organic ingredients in dietary supplements, and favorable government initiatives for hemp-derived cannabidiol are the key factors driving the growth. The segment is anticipated to witness the fastest CAGR during the forecast period, owing to an increase in the consumption of CBD-based nutraceutical products in health and wellness, sports nutrition, weight management, and other fields.
Based on distribution channels, retail pharmacies dominated the market for cannabidiol consumer health in 2023. An increase in the number of companies selling their products via retail pharmacies is fueling the growth of the segment. However, the online stores segment is anticipated to witness fastest growth over the forecast period. This can be attributed to the increase in penetration of e-commerce, rising demand for CBD-infused products, preference of consumers for buying CBD online, and easy availability of these products in emerging markets.
North America dominated the market in 2023, with a revenue share of 66.9%. The growing awareness about the medical benefits of CBD among consumers has resulted in greater sales of online and retail sales in the region. On the other hand, Europe is expected to be the fastest-growing region, owing to an increase in consumption, rising awareness, positive attitudes regarding CBD products, and strategic investments by major companies in the region.
Request a free sample copy or view report summary: CBD Consumer Health Market Report
Nutraceuticals dominated the market in 2023 with a revenue share of 63.9%, owing to the changing consumer preferences from chemical-based ingredients to organic and herbal ingredients in dietary supplements.
Online stores is anticipated to be the fastest-growing distribution channel segment over the forecast period, owing to the increase in penetration of e-commerce and the rising number of players offering their products online.
North America dominated the CBD consumer health market for cannabidiol consumer health products, with a revenue share of around 66.9% in 2023.
Grand View Research has segmented the global CBD consumer health market report based on product, distribution channel, and region.:
CBD Consumer Health Product Outlook (Revenue, USD Million, 2018 - 2030)
Medical OTC Products
CBD Analgesic Products
CBD Dermatology Products
CBD Mental Health Products
CBD Sleeping Aids Products
Other OTC Products
Nutraceuticals
CBD Vitamins and Dietary Supplements (VDS)
CBD Sports Nutrition
CBD Weight Management and Wellbeing
CBD Consumer Health Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Online Stores
Retail Stores
Retail Pharmacies
CBD Consumer Health Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
India
China
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of CBD Consumer Health Market
Elixinol
ENDOCA
NuLeaf Naturals, LLC
Kazmira
Charlotte's Web, Inc.
Joy Organics
The Cronos Group
Medical Marijuana, Inc.
CV Sciences, Inc.
Isodiol International Inc.
"The quality of research they have done for us has been excellent..."